Eligibility criteria  | How to apply |  Selection process  |  Fellowships Available  | Call Calendar | Contact

Apply now to boost your scientific career at VHIO, a Center of Excellence backed by first class core technologies and a broad training portfolio in one of the best translational, preclinical and clinical research centers in Europe.    VHIO has a unique staff of international researchers who are devoted to delivering on the promise of providing precision medicine in oncology and turning discoveries in cancer research into more effective treatments and better practices to care for our patients.
PhD Fellows will benefit from an exciting scientific environment and an integrated training programme, including access to state-of-the-art infrastructure, lectures and seminars, specialized scientific and technological courses, complementary skills training and career development activities, as well as social activities.

Check below our fully funded scholarships for international Life Sciences & Medical students:

• SERRANO Lab – Computational Biology & Bioinformatics | Chromosome Instability | Tumor Evolution | Copy Number Alterations | Driver Selection

APPLICATION DEADLINE EXTENDED TO JANUARY 29, 2024

The project aims to uncover cell-lineage-specific patterns of chromosome instability along with the critical driver events involved in the cytogenetic progression and evolution of malignant tumors of mesenchymal origin. By interrogating unique multi-omics datasets and using cutting-edge technologies and methodologies in clinically-relevant experimental models, the PhD student will delve into the underlying biological mechanisms of chromosome instability with the final goal of generating molecular classification and developing novel therapeutic strategies.

Candidates with background in both Bioinformatics and Molecular Biology will be prioritized. This PhD project will be co-supervised by Dr. Francisco Martínez-Jiménez, from the Computational Immunogenomics Group.

• BARRIGA Lab – Cancer Genetics | Copy Number Alterations | Tumor Immunology | Genome Engineering | Immune Evasion

NO LONGER ACCEPTING APPLICATIONS

The project is focused on understanding the mechanisms by which large genomic deletions enable cancer cells to avoid the immune system in the context of disease progression and resistance to immunotherapy. By using state of the art genome engineering, mouse models of cancer, immunophenotyping, and CRISPR screening, the PhD student will dissect the biology and vulnerabilities associated to recurrent copy number alterations in pancreas cancer.

Although no a priori skills are required, candidates with experience in molecular biology, genetics, CRISPR-Cas9, and in vivo work will be prioritized.